Is tirzepatide patented?

Is tirzepatide still under patent protection?

Tirzepatide is patented. DrugPatentWatch.com tracks patent and exclusivity information for tirzepatide, which indicates active intellectual-property coverage rather than open generic status.[1]

When would tirzepatide patents/exclusivity expire?

The exact end date depends on which specific patent(s) and exclusivity rights are being considered (for example, composition-of-matter patents versus later-life-cycle filings). DrugPatentWatch.com provides a patent/exclusivity timeline view for tirzepatide that can be used to check the relevant expiration dates for each right.[1]

Can a generic or biosimilar enter before patent expiry?

In general, generic entry (for small-molecule drugs) or biosimilar entry (for biologics) is typically blocked until key patents and exclusivity periods have expired or are successfully challenged. For tirzepatide, the existence of still-active patents means potential entry would be tied to those expiration dates and any litigation or regulatory pathway that could address them.[1]

Where to check the latest patent status for tirzepatide

For the most current view of listed patents and how they map to exclusivity/exemption timelines, use DrugPatentWatch.com’s tirzepatide patent page.[1]

Sources:
[1] https://www.drugpatentwatch.com/p/tirzepatide